2019


  1. Beutler J, Jentsch HFR, Rodloff AC, Stingu CS (2019). Bacteremia after professional mechanical plaque removal in patients with chronic periodontitis. Oral Dis, 00, 00.
     
  2. Wendt S, Trawinski H, Schubert S, Rodloff AC, Mössner J, Lübbert C (2019). Diagnostik und Therapie des Madenwurmbefalls Deutsches Ärzteblatt, 13, 213-219.
     
  3. Jentzsch M, Schwind S, Vucinic V, Wendt S, Stingu CS, Niederwieser D, Weidhase L (2019). [Meningococcal sepsis without cerebrospinal fluid abnormalities under treatment with eculizumab]. Med Klin Intensivmed Notfmed, 00, 00.
     
  4. Schimmel T, Trawinski H, Karlas T, Wendt S, Lübbert C (2019). Polymikrobielle Leberabszesse und Pleuraempyem bei einem 40-jährigen Mann nach Zahnextraktion und geschlossener Parodontitis-Behandlung: Ein Fallbericht Z Gastroenterol, 57, 1-6.
     


  5. 2018


  6. Wendt S, Lubbert C, Karlas T (2018). An Emerging Cause for Liver Abscesses With Poor Prognosis. Gastroenterology, 155(1), e18-e19.
     
  7. Schulz-Stubner S, Reska M, Schaumann R (2018). Affected healthcare workers during outbreaks: A report from the German consulting center for infection control (BZH) outbreak registry. Infect Control Hosp Epidemiol, 31, 1-3.
     
  8. Sanchez Ramos L, Rodloff AC (2018). Identification of Clostridium species using the VITEK® MS. Anaerobe, 00, 00.
     
  9. Wendt S, Lippmann N, Fahnert J, Rodloff AC, Lubbert C (2018). Brucella related myocarditis. Int J Infect Dis, 66, 126-127.
     
  10. Lippmann N, Wendt S, Lübbert C (2018). 44 year old female africa traveller with worm-like structure in the stool. Dtsch Med Wochenschr, 66, 126-127.
     
  11. Rodloff AC, Dowzicky MJ (2018). In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010-2016. Anaerobe, 51, 78-88.
     
  12. Eder IB, Wendt S, Lipek T (2018). Extraintestinale Oxyuriasis. Deutsches Ärzteblatt, 115(18), 326.
     
  13. Nabert-Georgi C, Rodloff AC, Jentsch H, Reissmann DR, Schaumann R, Stingu CS (2018). Influence of oral bacteria on adhesion of Streptococcus mutans and Streptococcus sanguinis to dental materials. Clin Exp Dent Res, 4(3), 72-77.
     
  14. Schaumann R, Dallacker-Losensky K, Rosenkranz C, Genzel GH, Stingu CS, Schellenberger W, Schulz-Stubner S, Rodloff AC, Eschrich K (2018). Discrimination of Human Pathogen Clostridium Species Especially of the Heterogeneous C. sporogenes and C. botulinum by MALDI-TOF Mass Spectrometry. Curr Microbiol, 00, 00.
     
  15. Olms C, Yahiaoui-Doktor M, Remmerbach TW, Stingu CS (2018). Bacterial Colonization and Tissue Compatibility of Denture Base Resins. Dent J (Basel), 6(2), 1-12.
     
  16. Sukumar MR, Konig B (2018). Pomegranate extract specifically inhibits Clostridium difficile growth and toxin production without disturbing the beneficial bacteria in vitro. Infect Drug Resist, 11, 2357-2362.
     
  17. Efunshile AM, Ezeanosike O, Onyekachi ONI, Ugwu MI, Konig B, Robertson LJ (2018). Apparent absence of Giardia infections among children under 5-years of age with acute watery diarrhoea in Abakaliki, Nigeria. Epidemiol Infect, 3, 1-5.
     
  18. Kaiser T, Finstermeier K, Hantzsch M, Faucheux S, Kaase M, Eckmanns T, Bercker S, Kaisers UX, Lippmann N, Rodloff AC, Thiery J, Lubbert C (2018). Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant Klebsiella pneumoniae. Am J Infect Control, 46(1), 54-59.
     
  19. Blod C, Schlichting N, Schulin S, Suttkus A, Peukert N, Stingu CS, Hirsch C, Elger W, Lacher M, Buhligen U, Mayer S (2018). The oral microbiome-the relevant reservoir for acute pediatric appendicitis? Int J Colorectal Dis, 33(2), 209-218.
     
  20. Kaiser T, Finstermeier K, Hantzsch M, Faucheux S, Kaase M, Eckmanns T, Bercker S, Kaisers UX, Lippmann N, Rodloff AC, Thiery J, Lubbert C (2018). Stalking a lethal superbug by whole-genome sequencing and phylogenetics: Influence on unraveling a major hospital outbreak of carbapenem-resistant Klebsiella pneumoniae. Am J Infect Control, 46(1), 54-59.
     
  21. Kohler AT, Rodloff AC, Labahn M, Reinhardt M, Truyen U, Speck S (2018). Efficacy of sodium hypochlorite against multidrug-resistant gram-negative bacteria. J Hosp Infect, 00, 00.
     
  22. Lübbert C, Wendt S, Sander C, Beeskow A, Becker-Rux D (2018). Intracranial hypertension and vasculitic infarction in a patient with severe cerebral melioidosis Lancet Infect Dis, 18, 1160.
     
  23. Ny S, Kozlov R, Dumpis U, Edquist P, Grondahl-Yli-Hannuksela K, Kling AM, Lis DO, Lubbert C, Pomorska-Wesolowska M, Palagin I, Vilde A, Vuopio J, Walter J, Wisell KT (2018). Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia. Eur J Clin Microbiol Infect Dis, 37(12), 2347-2354.
     
  24. Lubbert C, Lippmann N, von Braun A (2018). [New Guidelines and Data to Clostridium difficile - What's New?] Dtsch Med Wochenschr, 143(11), 787-792.
     
  25. Oberbach A, Friedrich M, Feder S, Buschmann T, Gräber S, Rodloff A, Schlichting N, Kullnick Y, Lehmann S, Luehr M, Peterß S, Pichlmaier M, Borger M, Hagl C, Bagaev E (2018). Bacterial Infiltration of Structural Heart Valve Disease The Thoracic and Cardiovascular Surgeon, 66, 110.
     


  26. 2017


  27. Rodloff AC, Dowzicky MJ (2017). Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014). Chemotherapy, 62(1), 1-11.
     
  28. Stingu CS, Eschrich K, Thiel J, Borgmann T, Schaumann R, Rodloff AC (2017). Identification of viridans streptococci With Matrix-Assisted Laser Desorption & Ionization Time-of-flight Mass Spectrometry by an In-house Method and a Commercially Available System. Ann Lab Med, 37(5), 434-437.
     
  29. Wendt S, Eder I, Wölfel R, Braun P, Lippmann N, Rodloff A (2017). [Botulismus: Diagnostik und Therapie.] Dtsch Med Wochenschr, 142(17), 1304-1312.
     
  30. Hoza AS, Mfinanga SGS, Moser I, Konig B (2017). Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat? BMC Infect Dis, 17(1), 407.
     
  31. Debebe T, Biagi E, Soverini M, Holtze S, Hildebrandt TB, Birkemeyer C, Wyohannis D, Lemma A, Brigidi P, Savkovic V, Konig B, Candela M, Birkenmeier G (2017). Unraveling the gut microbiome of the long-lived naked mole-rat. Sci Rep, 7(1), 9590.
     
  32. Fill Malfertheiner S, Wendt S, Layer F, Weigl M, Seelbach-Gobel B, Konig W, Konig B (2017). Prevalence, clonality, and pathogenicity of Staphylococcus epidermidis isolates in newborn feces. Eur J Clin Microbiol Infect Dis, 36(10), 1955-1964.
     
  33. König B (2017). Die Bedeutung des Mikrobioms bei Neugeborenen. Neonatologie Scan, 6(3), 219-229.
     
  34. Eder I, Vollmar P, Pfeffer M, Naether P, Rodloff AC, Meyer H (2017). Two Distinct Clinical Courses of Human Cowpox, Germany, 2015. Viruses, 9(12), e375.
     
  35. Dietze N, Wendt S, Weidhase L (2017). Invasive Pilzinfektion bei Immunsupprimierten. Deutsches Ärzteblatt, 50, 874.
     
  36. Stîngu CS, Bethmann F, Eisermann P, Wendt S, Rodloff AC (2017). In Vitro Activity Of Tigecycline And Imipenem Evaluated Under Aerobic And Anaerobic Conditions. Romanian Achives of Microbiology and Immunology, 76(2), 65-70.
     
  37. Rodloff AC, Dietze N, Roth A (2017). Antibiotika: was geht, was geht nicht? OUP, 12, 615-617.
     
  38. Reuken PA, Torres D, Baier M, Loffler B, Lubbert C, Lippmann N, Stallmach A, Bruns T (2017). Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. PLoS One, 12(1), e0169900.
     
  39. Lubbert C, Baars C, Dayakar A, Lippmann N, Rodloff AC, Kinzig M, Sorgel F (2017). Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens. Infection, 45(4), 479-491.
     
  40. Oberbach A, Schlichting N, Feder S, Lehmann S, Kullnick Y, Buschmann T, Blumert C, Horn F, Neuhaus J, Neujahr R, Bagaev E, Hagl C, Pichlmaier M, Rodloff AC, Graber S, Kirsch K, Sandri M, Kumbhari V, B (2017). New insights into valve-related intramural and intracellular bacterial diversity in infective endocarditis. PLoS One, 12(4), e0175569.
     
  41. Reuken PA, Torres D, Baier M, Loffler B, Lubbert C, Lippmann N, Stallmach A, Bruns T (2017). Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. PLoS One, 12(2), e0172373.
     
  42. Wolf L, Lippmann N, Petzold-Quinque S, Siekmeyer M, Kieß W (2017). A Fulminant Case of Haemophilus influenzae Serotype F Meningitis in an Immunocompetent 3-Years-Old Boy. J Pediatr Infect Dis, 0, 00.
     
  43. Richter A, Eder I, Konig B, Lutze B, Rodloff AC, Thome UH, Weiss M, Chaberny IF (2017). [Decolonization of Health Care Workers In a Neonatal Intensive Care Unit Carrying a Methicillin-Susceptible Staphylococcus aureus Isolate]. Gesundheitswesen, 00, 00.
     
  44. Bodmann KF, Grabein B, Kresken M, Derendorf H, Stahlmann R, Ott SR, Olzowy B, Eckmann C, Wagenlehner F, Sunderkötter C, Voßen M, Dohmen PM, Shah PM, Mutters R, Walger P, Wilke M für die Expertenkommis (2017). S2k Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018 AWMF, 2017, 1-446.
     
  45. Schülin S, Schlichting N, Blod C, Opitz S, Suttkus A, Stingu CS, Barry K, Lacher M, Bühligen U, Mayer S (2017). The intra- and extraluminal appendiceal microbiome in pediatric patients. Medicine, 96(52), e9518.
     
  46. Lippmann N, Rodloff AC (2017). 2 Für den Gastroenterologen wichtige diagnostische Verfahren, Präanalytik 2.1 Bakteriologische Verfahren, Präanalytik 2.1.1 Für den Gastroenterologen wichtige mikrobiologische Verfahren In: Lübbert C, Vogelmann R, Gastroenterologische Infektiologie. (S. 5-7), Berlin/Boston: De Gruyter.
     
  47. Rodloff AC (2017). 3 Antibiotika 3.1 Antibiotika - Grundlagen In: Lübbert C, Vogelmann R, Gastroenterologische Infektiologie. (S. 29-36), Berlin/Boston: De Gruyter.
     


  48. 2016


  49. Hoza AS, Mfinanga SG, Rodloff AC, Moser I, Konig B (2016). Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes. BMC Res Notes, 9(1), 109.
     
  50. Hoza AS, Mfinanga SG, Moser I, Konig B (2016). Molecular characterization of Mycobacterium tuberculosis isolates from Tanga, Tanzania: First insight of MIRU-VNTR and microarray-based spoligotyping in a high burden country. Tuberculosis (Edinb), 98, 116-124.
     
  51. Debebe T, Holtze S, Morhart M, Hildebrandt TB, Rodewald S, Huse K, Platzer M, Wyohannes D, Yirga S, Lemma A, Thieme R, Konig B, Birkenmeier G (2016). Analysis of cultivable microbiota and diet intake pattern of the long-lived naked mole-rat. Gut Pathog, 8, 25.
     
  52. Lubbert C, Wendt K, Feisthammel J, Moter A, Lippmann N, Busch T, Mossner J, Hoffmeister A, Rodloff AC (2016). Epidemiology and Resistance Patterns of Bacterial and Fungal Colonization of Biliary Plastic Stents: A Prospective Cohort Study. PLoS One, 11(5), e0155479.
     
  53. Efunshile AM, Oduyebo O, Osuagwu CS, Koenig B (2016). Species distribution and antifungal susceptibility pattern of candida isolates from pregnant women in a tertiary hospital in Nigeria African Journal of Clinical and Experimental Microbiology, 17(3), 183-189.
     
  54. Hoza AS, Lupindu AM, Mfinanga SGM, Moser I, König B (2016). The role of nontuberculous mycobacteria in the diagnosis, management and quantifying risks of tuberculosis in Tanga, Tanzania Tanzania Journal of Health Research, 18(2), 5.
     
  55. Ekuma AE, Oduyebo OO, Efunshile AM, König B (2016). Surveillance for vancomycin resistant enterococci in a tertiary Institution in South Western Nigeria Afr J Infect Dis, 10(2), 121-126.
     
  56. Schulz-Stubner S, Reska M, Hauer T, Schaumann R (2016). [First Results of the German consulting center for infection control outbreak registry]. Dtsch Med Wochenschr, 141(6), e47-52.
     
  57. Lubbert C, Zimmermann L, Borchert J, Horner B, Mutters R, Rodloff AC (2016). Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis. Infect Dis Ther, 5(4), 545-554.
     
  58. Rodloff AC, Dowzicky MJ (2016). Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014). Chemotherapy, 62(1), 1-11.
     
  59. Elikwu CJ, Oduyeb O, Ogunsola FT, Anorlu RI, Okoromah CN, König B (2016). High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria The Pan African Medical Journal, 25, 249.
     
  60. Debebe T, Kruger M, Huse K, Kacza J, Muhlberg K, Konig B, Birkenmeier G (2016). Ethyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and Biofilms. PLoS One, 11(9), e0162919.
     
  61. Elikwu CJ, Oduyebo OO, Anorlu RI, König B (2016). Antibiotic susceptibility/resistant gene profiles of Group B streptococci isolates from pregnant women in a tertiary institution in Nigeria Journal of Clinical Sciences, 13(3), 132-136.
     
  62. Fehrenbach MK, Bernhard M, Siekmeyer M, Lippmann N, Kiess W, Nestler U, Meixensberger J, Preuss M (2016). VP-shunt dysfunction caused by malaria CNS infection. Childs Nerv Syst, 32(4), 759-760.
     
  63. Gerlach MM, Lippmann N, Kobelt L, Petzold-Quinque S, Ritter L, Kiess W, Siekmeyer M (2016). Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident. Infection, 44(3), 361-364.
     
  64. Zajonz D, Wuthe L, Rodloff AC, Prietzel T, von Salis-Soglio GF, Roth A, Heyde CE, Josten C, Ghanem M (2016). [Infections of hip and knee endoprostheses : Spectrum of pathogens and the role of multiresistant bacteria]. Chirurg, 87(4), 332-339.
     
  65. Hutschenreuther A, Bigl M, Hemdan NY, Debebe T, Gaunitz F, Birkenmeier G (2016). Modulation of GLO1 Expression Affects Malignant Properties of Cells. Int J Mol Sci, 17(12), E2133.
     
  66. Bielicki JA, Sharland M, Johnson AP, Henderson KL, Cromwell DA (2016). Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data. J Antimicrob Chemother, 71(3), 794-802.
     
  67. Birkenmeier G, Hemdan NY, Kurz S, Bigl M, Pieroh P, Debebe T, Buchold M, Thieme R, Wichmann G, Dehghani F (2016). Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells. PLoS One, 11(8), e0161571.
     
  68. Rodloff AC (2016). Kapitel 39: Obligat anaerobe, sporenbildende Stäbchen (Clostridien). Kapitel 40: Obligat anaerobe, nichtsporenbildende Bakterien. In: Suerbaum S, Burchard GD, Kaufmann SHE, Schulz TF, Medizinische Mikrobiologie und Infektiologie. (S. 321-336), Berlin, Heidelberg: Springer Verlag.
     


  69. 2015


  70. Biadglegne F, Rodloff AC, Sack U (2015). Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect, 143(5), 887-900.
     
  71. Lübbert C, Straube L, Stein C, Makarewicz O, Schubert S, Mössner J, Pletz MW, Rodloff AC (2015). Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol, 305(1), 148-56.
     
  72. Stingu CS, Borgmann T, Rodloff AC, Vielkind P, Jentsch H, Schellenberger W, Eschrich K (2015). Rapid identification of oral Actinomyces species cultivated from subgingival biofilm by MALDI-TOF-MS. J Oral Microbiol, 7, e26110.
     
  73. Efunshile AM, Olawale T, Stensvold CR, Kurtzhals JA, Konig B (2015). Epidemiological study of the association between malaria and helminth infections in Nigeria. Am J Trop Med Hyg, 92(3), 578-582.
     
  74. Efunshile MA, Ngwu BA, Kurtzhals JA, Sahar S, Konig B, Stensvold CR (2015). Molecular Detection of the Carriage Rate of Four Intestinal Protozoa with Real-Time Polymerase Chain Reaction: Possible Overdiagnosis of Entamoeba histolytica in Nigeria. Am J Trop Med Hyg, 93(2), 257-262.
     
  75. Vielkind P, Jentsch H, Eschrich K, Rodloff AC, Stingu CS (2015). Prevalence of Actinomyces spp. in patients with chronic periodontitis. Int J Med Microbiol, 305(7), 682-688.
     
  76. Biadglegne F, Merker M, Sack U, Rodloff AC, Niemann S (2015). Tuberculous Lymphadenitis in Ethiopia Predominantly Caused by Strains Belonging to the Delhi/CAS Lineage and Newly Identified Ethiopian Clades of the Mycobacterium tuberculosis Complex. PLoS One, 10(9), e0137865.
     
  77. Hoza AS, Mfinanga SG, Konig B (2015). Anti-TB drug resistance in Tanga, Tanzania: A cross sectional facility-base prevalence among pulmonary TB patients. Asian Pac J Trop Med, 8(11), 907-913.
     
  78. Ducomble T, Faucheux S, Helbig U, Kaisers UX, Konig B, Knaust A, Lubbert C, Moller I, Rodloff AC, Schweickert B, Eckmanns T (2015). Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction. J Hosp Infect, 89(3), 179-185.
     
  79. Meyer F, Buerger T, Halloul Z, Lippert H, Konig B, Tautenhahn J (2015). Effects Of Gelatine-Coated Vascular Grafts On Human Neutrophils. Pol Przegl Chir, 87(9), 443-452.
     
  80. Hempel C, Boisen IM, Efunshile A, Kurtzhals JA, Staalso T (2015). An automated method for determining the cytoadhesion of Plasmodium falciparum-infected erythrocytes to immobilized cells. Malar J, 14, 112.
     
  81. Lubbert C, Rodloff AC, Hamed K (2015). Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE). Infect Dis Ther, 4(3), 259-271.
     
  82. Bielicki JA, Lundin R, Sharland M (2015). Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Childrens Hospitals Varies Substantially from Adult Surveillance Data in Europe. Pediatr Infect Dis J, 34(7), 734-741.
     
  83. Lübbert C, Hau HM, Rodloff A, Mössner J, Mischnik A, Bercker S, Bartels M, Kaisers UX (2015). Klinische Bedeutung von Infektionen durch Carbapenem-resistente Enterobakterien bei Lebertransplantierten. Z Gastroenterol, 53(11), 1276-1287.
     
  84. Jentsch H, Purschwitz R, Stingu CS, Schmidt J, Sack U (2015). Reduced numbers of peripheral blood CD27+ IgD- memory B cells in patients with aggressive periodontitis Verringerte Anzahl von CD27+ IgD- Memory-B-Zellen im peripheren Blut von Patienten mit aggressiver Periodontitis LaboratoriumsMedizin, 39(3), 129-133.
     
  85. Trawinski H, Graber S, Leifels M, Schubert S, Lubbert C (2015). [Undulant fever and autoimmune hemolytic anemia in a 20-year-old exchange student from Jordan - the human brucellosis as an important differential diagnosis in migrants]. Dtsch Med Wochenschr, 140(24), 1848-1852.
     


  86. 2014


  87. Lubbert C, Lippmann N, Busch T, Kaisers UX, Ducomble T, Eckmanns T, Rodloff AC (2014). Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. Am J Infect Control, 42(4), 376-380.
     
  88. Lippmann N, Lubbert C, Kaiser T, Kaisers UX, Rodloff AC (2014). Clinical epidemiology of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis, 14(4), 271-272.
     
  89. Rodloff AC (2014). Fallstricke bei der Resistenzbestimmung. Medizinische Klinik Intensivmedizin und Notfallmedizin, 109(3), 182-186.
     
  90. Biadglegne F, Rodloff AC, Sack U (2014). A First Insight into High Prevalence of Undiagnosed Smear-Negative Pulmonary Tuberculosis in Northern Ethiopian Prisons: Implications for Greater Investment and Quality Control. PLOS ONE, 9(9), e106869.
     
  91. Biadglegne F, Mulu A, Rodloff AC, Sack U (2014). Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia Tuberculosis, 94(5), 502-505.
     
  92. Biadglegne F, Tessema B, Sack U, Rodloff AC (2014). Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia Indian J Med Res, 140(1), 116-122.
     
  93. Genzel GH, Stubbings W, Stingu CS, Labischinski H, Schaumann R (2014). Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria. Int J Antimicrob Agents, 44(5), 420-423.
     
  94. Schulz-Stubner S, Schorer C, Ennker J, Bauer S, Schaumann R (2014). 72 hours standby time of wet-primed cardiopulmonary bypass circuits: a microbiological quality assurance study. Thorac Cardiovasc Surg, 62(7), 575-577.
     
  95. Biadglegne F, Sack U, Rodloff AC (2014). Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. Antimicrob Resist Infect Control, 3(1), 31.
     
  96. Lubbert C, Becker-Rux D, Rodloff AC, Laudi S, Busch T, Bartels M, Kaisers UX (2014). Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection, 42(2), 309-316.
     
  97. Weis S, John E, Lippmann N, Mossner J, Lubbert C (2014). [Clostridium difficile Infection (CDI) in the Course of Time - An Issue Only for the Internist?] Zentralbl Chir, 139(4), 460-468.
     
  98. Lubbert C, Rodloff AC, Laudi S, Simon P, Busch T, Mossner J, Bartels M, Kaisers UX (2014). Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing k. pneumoniae in liver transplant recipients. Liver Transpl, 20(6), 736-738.
     
  99. Kujath P, Eckmann C, Keck T, Rodloff A, Schlöricke E, Hoffmann M (2014). Acute and Chronic Infections of the Gastrointestinal Tract. Viszeralmedizin, 30(5), 342-345.
     
  100. Theophel K, Schacht VJ, Schlüter M, Schnell S, Stingu CS, Schaumann R, Bunge M (2014). The importance of growth kinetic analysis in determining bacterial susceptibility against antibiotics and silver nanoparticles. Front Microbiol, 5, 544.
     
  101. Wiltberger G, Schmelzle M, Schubert S, Lubbert C, Brandmaier P, Berg T, Pfeiffer D, Rodloff A, Mohr FW, Jonas S (2014). Invasive cardiac aspergillosis after orthotopic liver transplantation. Z Gastroenterol, 52(8), 813-817.
     
  102. Schnappauf C, Rodloff A, Siekmeyer W, Hirsch W, Sorge I, Schuster V, Kiess W (2014). Invasive pneumococcal diseases in children and adolescents-a single centre experience. BMC Res Notes, 7, 145.
     
  103. Praekelt U, Reissbrodt R, Kresse A, Pavankumar A, Sankaran K, James R, Jesudason M, Anandan S, Prakasam A, Balaji V, Dutta S, Dutta S, Ramamurthy T, Fischer R, Sander P, Schaumann R, Navarro A, Willia (2014). Monoclonal antibodies against all known variants of EspA: development of a simple diagnostic test for enteropathogenic Escherichia coli based on a key virulence factor. J Med Microbiol, 63(Pt12), 1595-1607.
     
  104. Schmidt J, Jentsch H, Stingu CS, Sack U (2014). General immune status and oral microbiology in patients with different forms of periodontitis and healthy control subjects. PLoS One, 9(10), e109187.
     
  105. Ruscher C, Pfeifer Y, Layer F, Schaumann R, Levin K, Mielke M (2014). Inguinal skin colonization with multidrug-resistant bacteria among residents of elderly care facilities: Frequency, persistence, molecular analysis and clinical impact. Int J Med Microbiol, 304(8), 1123-1134.
     
  106. Pulzer F, Lippmann N, Gebauer C, Bläser A, Knüpfer M, Thome U (2014). Candida Bloodstream Infections In A Nicu (Posterabstract) Arch Dis Child, 99(Suppl.2), A434.
     


  107. 2013


  108. Tessema B, Beer J, Merker M, Emmrich F, Sack U, Rodloff AC, Niemann S (2013). Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis, 13, e131.
     
  109. Biadglegne F, Anagaw B, Anagaw B, Tesfaye W, Tessema B, Sack U, Rodloff AC (2013). Tuberculosis Lymphadenitis in Northwest Ethiopia: Implications for Public Health. Open Journal of Medical Microbiology, 3(1), 18-24.
     
  110. Schaumann R, Janssen E, Funke M, Stingu CS, Genzel GH, Janssen M, Rodloff AC (2013). In vitro activities of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against Bacteroides fragilis strains evaluated by kill kinetics. J Med Microbiol, 62(Pt4), 576-581.
     
  111. Kruger M, Shehata AA, Schrodl W, Rodloff A (2013). Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum. Anaerobe, 20, 74-78.
     
  112. Stingu CS, Schaumann R, Jentsch H, Eschrich K, Brosteanu O, Rodloff AC (2013). Association of periodontitis with increased colonization by Prevotella nigrescens. J Investig Clin Dent, 4(1), 20-5.
     
  113. Biadglegne F, Anagaw B, Debebe T, Anagaw B,Tesfaye W, Tessema B, Rodloff A, Sack U (2013). Tuberculosis lymphadenitis and its treatment outcome in Felege Hiwot Referral Hospital, Northwest Ethiopia: a retrospective study. Int J Biol Med Res, 4(1), 2942-2947.
     
  114. Biadglegne F, Anagaw B, Debebe T, Anagaw B,Tesfaye W, Tessema B, Rodloff A, Sack U (2013). A retrospective study on the outcomes of tuberculosis treatment in Felege Hiwot Referral Hospital, Northwest Ethiopia. Int J Med Med Sci, 5(2), 85-91.
     
  115. Biadglegne F, Tesfaye W, Anagaw B, Tessema B, Debebe T, Anagaw B, Mulu A, Sack U, Rodloff AC (2013). Tuberculosis Lymphadenitis in Ethiopia. Jpn J Infect Dis, 66(4), 263-268.
     
  116. Biadglegne F, Tessema B, Rodloff AC, Sack U (2013). Magnitude of Gene Mutations Conferring Drug Resistance in Mycobacterium Tuberculosis Isolates from Lymph Node Aspirates in Ethiopia. Int J Med Sci, 10(11), 1589-1594.
     
  117. Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stingu CS, Schellenberger W, Rodloff AC, Eschrich K (2013). Discrimination of Enterobacteriaceae and non-fermenting gram negative bacili by MALDI-TOF mass spectrometry Open Microbiol J, 7, 118-122.
     
  118. Biadglegne F, Tesfaye W, Sack U, Rodloff AC (2013). Tuberculous lymphadenitis in northern ethiopia: in a public health and microbiological perspectives. PLoS One, 8(12), e81918.
     
  119. Efunshile AM, Abudu EK, Fowotade A, Makanjuola OB, Oyediran EIO, Olusanya OO, König B (2013). KNOWLEDGE OF HUMAN PAPILLOMAVIRUS (HPV), CERVICAL CANCER AND HPV VACCINES AMONG FEMALE HEALTHCARE WORKERS IN A NIGERIAN TERTIARY HOSPITAL. International Journal of Medical and Applied Sciences, 2(2), 38-46.
     
  120. Efunshile AM, Fowotade A, Makanjuola OB, Oyediran EI, Olusanya OO, Koenig B (2013). ANTIMALARIAL USE AND THE ASSOCIATED FACTORS IN RURAL NIGERIA FOLLOWING IMPLEMENTATION OF AFFORDABLE MEDICINES FACILITY-MALARIA (AMFM) PRICE SUBSIDY AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY, 14(2), 88-94.
     
  121. Lübbert C, Lippmann N, Rodloff AC (2013). Hochresistente Enterobakterien Systematisches Screening ist notwendig. Deutsches Ärzteblatt, 110(46), 2206-2207.
     
  122. Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, Macgowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G (2013). EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect, 19(2), 141-60.
     
  123. Fricke S, Hilger N, Oelkrug C, Rodloff AC, Fricke C (2013). Differentiation of fungi using hybridization probes on the LightCycler(®). Methods Mol Biol, 968, 93-104.
     
  124. Lübbert C, Faucheux S, Becker-Rux D, Laudi S, Dürrbeck A, Busch T, Gastmeier P, Eckmanns T, Rodloff AC, Kaisers U (2013). Rapid Emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents, 42(6), 565-570.
     


  125. 2012


  126. Kruger M, Grosse-Herrenthey A, Schrodl W, Gerlach A, Rodloff A (2012). Visceral botulism at dairy farms in Schleswig Holstein, Germany - Prevalence of Clostridium botulinum in feces of cows, in animal feeds, in feces of the farmers, and in house dust. Anaerobe, 18(2), 221-3.
     
  127. Rodloff AC, Kruger M (2012). Chronic Clostridium botulinum infections in farmers. Anaerobe, 18(2), 226-8.
     
  128. Fricke S, Fricke C, Oelkrug C, Blatz R, Schonfelder U, Niederwieser D, Hilger N, Ruhnke M, Rodloff AC (2012). A real-time PCR for the detection and characterisation of Aspergillus species. Mycoses, 55(5), 416-425.
     
  129. Schaumann R, Funke M, Janssen E, Rodloff AC (2012). In Vitro Activity of Clindamycin, Imipenem, Metronidazole, and Piperacillin-Tazobactam against Susceptible and Resistant Isolates of Bacteroides fragilis by Anaerobic Kill-Kinetics. Antimicrob Agents Chemother, 56(6), 3413-6.
     
  130. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC (2012). First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis, 16(6), 805-11.
     
  131. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC (2012). Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis, 12(1), e37.
     
  132. Stingu CS, Jentsch H, Eick S, Schaumann R, Knofler G, Rodloff A (2012). Microbial profile of patients with periodontitis compared with healthy subjects. Quintessence Int, 43(2), e23-31.
     
  133. AM Efunshile, A Fowotade, OB Makanjuola, EIO Oyediran, OO Olusanya, B Koenig (2012). Survey of Users' Perceptions of Clinical Microbiology Laboratory Services in Nigeria. Annals of Tropical Pathology, 3, 127-133.
     
  134. Mouton JW, Brown DF, Apfalter P, Canton R, Giske CG, Ivanova M, Macgowan AP, Rodloff A, Soussy CJ, Steinbakk M, Kahlmeter G (2012). The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect, 18(3), E37-E45.
     
  135. Schaumann R, Knoop N, Genzel GH, Losensky K, Rosenkranz C, Stingu CS, Schellenberger W, Rodloff AC, Eschrich K (2012). A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit, 18(9), 71-77.
     
  136. Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Florl C, Fegeler W, Becker K (2012). Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Mycoses, 55(3), 124-137.
     
  137. Ammon A, Autenrieth IB, Bange F-C, Bär W, Becker S, Berger A, Blasczyk R, et al (2012). Obligat anaerobe, sporenbildende Stäbchen (Clostridien); Obligat anaerobe, nichtsporenbildende Bakterien. In: Suerbaum S; Hahn H; Burchard G-D; Kaufmann SHE; Schulz TF, Medizinische Mikrobiologie und Infektiologie. (S. 324-340), Berlin: Springer-Verlag.
     
  138. Weiß G, König B (2012). Mikrobiologische Grundlagen und Diagnostik; Virale Infektionen; Pilzinfektionen: Diagnostik; Immunsupprimierte Patienten. In: Weiß G, König B, Infektionsmanagement auf Intensivstationen - Empfehlungen zur Diagnostik und Therapie nosokomialer Infektionen. (S. 1-41), München: Elsevier GmbH, Urban & Fischer Verlag.
     
  139. Geiss HK, Rodloff AC (2012). Bacteroides, Bilophila, Fusobacterium, Leptotrichia, Mobiluncus, Porphyromonas,Prevotella, Selenomonas, Wolinella. In: Darai G, Handermann M, Sonntag H-G, Zöller L, Lexikon der Infektionskrankheiten des Menschen. (S. 1-26), Heidelberg: Springer.
     
  140. Schaumann R, Schäfer V, Mauch H, Wacha H, Schöffel A, Rodloff AC (2012). Intraabdominelle Infektionen unter besonderer Berücksichtigung der Peritonitis. In: Podbielski A, Herrmann M, Kniehl E, Mauch H, Rüssmann H, MiQ Mikrobiologisch-infektiologische Qualitätsstandards (MiQ). (S. 1-52), München: Elsevier GmbH, Urban & Fischer Verlag.
     


  141. 2011


  142. Rodloff C, Koch D, Schaumann R (2011). Epidemiology and Antifungal Resistance in Invasive Candidiasis. Eur J Med Res, 16(4), 187-195.
     
  143. Htoutou Sedlakova M, Hanulik V, Chroma M, Hricova K, Kolar M, Schaumann R, Rodloff AC (2011). Phenotypic detection of broad-spectrum beta-lactamases in microbiological practice. Med Sci Monit, 17(5), 147-152.
     
  144. Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC (2011). Rate of recovery of Mycobacterium tuberculosis from frozen acid-fast-bacillus smear-positive sputum samples subjected to long-term storage in Northwest Ethiopia. J Clin Microbiol, 49(7), 2557-2561.
     
  145. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ (2011). Clostridium difficile infection in Europe: a hospital-based survey. Lancet, 377(9759), 63-73.
     
  146. Biadglegne F, Anagaw B, Tessema B, Getachew A, Andargie G, Abera B, Belyhun Y, Mulu A (2011). Voluntary HIV counseling and testing service in Northwest Ethiopia: the cases of counselor's perception, client's satisfaction, and in-service observations. Ethiop Med J, 49(3), 169-177.
     


  147. 2010


  148. Fricke S, Fricke C, Schimmelpfennig C, Oelkrug C, Schonfelder U, Blatz R, Zilch C, Faber S, Hilger N, Ruhnke M, Rodloff AC (2010). A real-time PCR assay for the differentiation of Candida species. J Appl Microbiol, 109(4), 1150-1158.
     
  149. Biadglegne F, Belyhun Y, Tessema B (2010). Sero-prevalence of human immunodeficiency virus (HIV) among voluntary counseling and testing (VCT) clients in Burie Health Center, West Gojjam, Ethiopia. Ethiop Med J, 48(2), 149-156.
     
  150. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U (2010). Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis, 10, 111ff.
     
  151. Tessema B, Biadglegne F, Mulu A, Getachew A, Emmrich F, Sack U (2010). Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther, 7, 2ff.
     
  152. Schaumann R (2010). Die Gefahr der Biofilmbildung. Risk of Biofilm Formation. BIOmaterialien, 11(1), 46.
     
  153. Rodloff AC, Kanj SS (2010). Complicated Infections: An Overview. Module 1. Lectures in The Management of Complicated Infections in Patients at Risk of Resistant Pathogens, 1, 1-23.
     
  154. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, Rodloff A, Fu W, Ling TA (2010). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol, 48(4), 1366-1377.
     
  155. Reissmann S, Friedrichs C, Rajkumari R, Itzek A, Fulde M, Rodloff AC, Brahmadathan KN, Chhatwal GS, Nitsche-Schmitz DP (2010). Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India. Emerg Infect Dis, 16(4), 656-663.
     
  156. Itzek A, Gillen CM, Fulde M, Friedrichs C, Rodloff AC, Chhatwal GS, Nitsche-Schmitz DP (2010). Contribution of Plasminogen Activation towards the Pathogenic Potential of Oral Streptococci. PLoS One, 5(11), e13826.
     
  157. Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J, Schubert S, Eckmanns T (2010). Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006. Infection, 38(1), 47-51.
     
  158. Bodmann KF und die Expertenkommission der Infektliga (2010). Komplizierte intraabdominelle Infektionen: Erreger, Resistenzen. Empfehlungen der Infektliga zur Antibiotikatherapie. Chirurg, 81(1), 38-49.
     
  159. Richter E, Beer J, Diel R, Hillemann D, Hoffmann H, Klotz M, Mauch H, Rüsch-Gerdes S (2010). MIQ 5: Tuberkulose. Mykobakteriose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. In: Podbielski A, Herrmann M, Kniehl E, Mauch H, Rüssmann H, MIQ 5: Tuberkulose. Mykobakteriose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. (S. 1-78), München: Elsevier GmbH.
     
  160. Bodmann KF, Grabein B und die Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie eV (2010). Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2010. In: Paul-Ehrlich-Gesellschaft für Chemotherapie e. V., Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2010. (S. 1-91), Rheinbach: Paul-Ehrlich-Gesellschaft für Chemotherapie e. V..
     


  161. 2009


  162. Schroeter M, Alpers K, Van Treeck U, Frank C, Rosenkoetter N, Schaumann R (2009). Outbreak of wound botulism in injecting drug users. Epidemiol Infect, 137(11), 1602-1608.
     
  163. Rodloff A, Gould I (2009). New views on Clostridium difficile infections: Introduction. Int J Antimicrob Agents, 33(Suppl 1), 1.
     
  164. Genzel GH, Schaumann R, Beer J, Blatz R, Rodloff AC (2009). Wundbotulismus bei heroinabhängigen Patienten. Mikrobiologe, 19(1), 28-32.
     
  165. Lebert C, Scherbel G, Rodloff AC (2009). Echinocandine. Chemotherapie Journal, 18(4), 126-137.
     
  166. Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U (2009). Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five--year retrospective study. BMC Public Health, 9, 371.
     
  167. Stingu CS, Turcu T, Dimitriu S (2009). A Comparison Between a Rapid Antigen Test and Culture in Diagnosis of Group A Streptococcal Pharyngitis Infect Dis Clin Pract, 17(5), 354-355.
     
  168. Rodloff A (2009). Prof. Dr. med. habil. Christian Tauchnitz zum 75. Geburtstag Ärzteblatt Sachsen, 20(7), 406.
     
  169. Hoheisel G, Vogtmann M, Gessner C, Winkler J, Rodloff AC, Wirtz H (2009). [Tuberculosis and travelling] Pneumologie, 63(9), 519-525.
     
  170. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ (2009). Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis, 65(1), 27-34.
     
  171. Hoheisel G, Hagert-Winkler A, Winkler J, Kahn T, Rodloff AC, Wirtz H, Gillissen A (2009). [Pulmonary and pleural tuberculosis in the elderly] Med Klin (Munich), 104(10), 772-779.
     
  172. Mikolajewska A, Genzel G, Borte G, Niederwieser D, Lange T (2009). Complete Resolution of a Pulmonary Aspergillosis on Third-Line Posaconazole and Immunosupression Taper After Allogeneic Hematopoietic Cell Transplantation. Infect Dis Clin Pract, 17(5), 339-341.
     
  173. Adam D, Bodmann KF, Elies W, Lebert C, Naber K, Simons K, Vogel F, Wacha H, Höhl R, Kujath P, Pross A, Rodloff A et al. (2009). Orale Antibiotika in Klinik und Praxis. In: Adam D, Bodmann KF, Elies W, Lebert C, Naber K, Simons K, Vogel F, Wacha H, Höhl R, Kujath P, Pross, Orale Antibiotika in Klinik und Praxis. (S. 1-20), Heidelberg: Springer Medizin Verlag.
     
  174. Lode H, Rodloff AC, Stahlmann R (2009). Therapie der Pneumonie mit parenteralen Antibiotika. Kurzes Therapiehandbuch für Kliniker. In: Lode H, Rodloff AC, Stahlmann R, Therapie der Pneumonie mit parenteralen Antibiotika. Kurzes Therapiehandbuch für Kliniker. (S. 1-128), Steinen: Zett-Verlag.
     
  175. Schaumann R, Rodloff AC (2009). Clostridium spp. In: Neumeister B, Geiss HK, Braun RW, Kimmig P, Mikrobiologische Diagnostik. Bakteriologie - Mykologie - Virologie - Parasitologie. (S. 539-550), Stuttgart, New York: Georg Thieme Verlag.
     
  176. Rodloff AC (2009). Antimikrobielle Empfindlichkeitstestung: Grundlagen, Verfahren, Standards. In: Neumeister B, Geiss HK, Braun RW, Kimmig P, Mikrobiologische Diagnostik. Bakteriologie - Mykologie - Virologie - Parasitologie. (S. 259-267), Stuttgart, New York : Georg Thieme Verlag.
     
  177. Schaumann R, Rodloff AC (2009). Low-Grade Infection and Multiresistant Gram-Positive Cocci. In: Kienapfel H, Kühn KD, The Infected Implant. (S. 85-89), Heidelberg: Springer medizin Verlag.
     
  178. Kujath P, Michelsen A, Rodloff AC (2009). Definition, Historie, Klassifikation und Epidemiologie des Diabetes mellitus; Pathophysiologie; Epidemiologie des diabetischen Fußsyndroms; Diagnostik; Therapie des diabetischen Fußsyndroms. In: Kujath P, Das diabetische Fußulkus - Interdisziplinäre Konzepte zur Prävention und Therapie. (S. 11-58), Bremen: UNI-MED Verlag AG.
     


  179. 2008


  180. Rodloff AC, Leclercq R, Debbia EA, Canton R, Oppenheim BA, Dowzicky MJ (2008). Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial. Clin Microbiol Infect, 14(4), 307-314.
     
  181. Kujath P, Hoffmann M, Rodloff A (2008). [Antimicrobial and antimycotic therapy of intra-abdominal infections] Chirurg, 79(4), 295-305.
     
  182. Schaumann R, Laurin F, Rodloff AC (2008). Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting. Int J Hyg Environ Health, 211(3-4), 292-298.
     
  183. Stingu CS, Rodloff AC, Jentsch H, Schaumann R, Eschrich K (2008). Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. Oral Microbiol Immunol, 23(5), 372-376.
     
  184. Stingu CS, Eschrich K, Rodloff AC, Schaumann R, Jentsch H (2008). Periodontitis is associated with a loss of colonization by Streptococcus sanguinis. J Med Microbiol, 57(Pt 4), 495-499.
     
  185. Schaumann R, Genzel G, Rodloff AC (2008). Untersuchungen zur Begasung von Anaerobiertöpfen mit dem anavac 104 T Anaeroben-Begasungssystem. Mikrobiologe, 18(3), 115-116.
     
  186. Rodloff A, Bauer T, Ewig S, Kujath P, Müller E (2008). Sensibel, intermediär und resistent - Wirkintensität von Antibiotika. Deutsches Ärzteblatt, 105(39), 657-662.
     
  187. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ng KP, Colombo A, Finquelievich J, Barnes R, Wadula J (2008). Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol, 46(3), 842-849.
     
  188. von Oettingen J, Nath-Chowdhury M, Ward BJ, Rodloff AC, Arrowood MJ, Ndao M (2008). High-yield amplification of Cryptosporidium parvum in interferon gamma receptor knockout mice. Parasitology, 135(10), 1151-1156.
     
  189. Hoheisel G, Winkler J, Gessner C, Hammerschmidt S, Seyfarth HJ, Rodloff AC, Liebert UG, Wirtz H, Gillissen A (2008). [Clinical features and diagnosis of bronchopulmonary infections in the elderly] Pneumologie, 62(5), 297-304.
     
  190. Grosse-Herrenthey A, Maier T, Gessler F, Schaumann R, Bohnel H, Kostrzewa M, Kruger M (2008). Challenging the problem of clostridial identification with matrix-assisted laser desorption and ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Anaerobe, 14(4), 242-249.
     
  191. Handrick W, Rodloff A, Borte M (2008). Infektionen bei Patienten mit systemischem Lupus erythematodes - eine Übersicht. Akt Rheumatol, 33(3), 171-176.
     
  192. Steppberger K, Meyer-Henn C, Falkenberg C, Schuster V, Rodloff AC, Kiess W (2008). Mikrobielle Besiedelung bei Mukoviszidose- Patienten an einem Zentrum für Kinderund Jugendmedizin Kinder- und Jugendmedizin, 8(5), 303-309.
     
  193. Hoheisel G, Vogtmann M, Winkler J, Gessner Ch, Hammerschmidt S, Seyfarth HJ, Reimann S, Rodloff AC, Gillissen A, Wirtz H (2008). Spektrum tuberkulöser Erkrankungen in der pneumologischen Praxis. Med Klin (Munich), 103(11), 769-777.
     
  194. Renner R, Fleck A, Schubert S, Beer J, Baerwald C, Holl-Ulrich K, Sticherling M (2008). Chronic urticaria and angioedema resulting from trichinella infection Acta Derm Venereol, 88(1), 78-79.
     
  195. Ackermann G, von Salis-Soglio G, Rodloff AC (2008). Krank wird man auch im Krankenhaus. In: Geiss HK, Jacobs E, Mack D , Der klinisch-infektiologische Fall. Problemorientierte Diagnose und Therapie. 43 neue, spannende Fälle. (S. 119-121), Heidelberg: Springer Medizin Verlag.
     


  196. 2007


  197. Russmann H, Panthel K, Bader RC, Schmitt C, Schaumann R (2007). Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens. Eur J Clin Microbiol Infect Dis, 26(2), 115-119.
     
  198. Schaumann R, Rodloff AC (2007). Activities of quinolones against obligately anaerobic bacteria Anti-Infective Agents in Medicinal Chemistry, 6(1), 49-56.
     
  199. Schaumann R, Rodloff AC (2007). Diagnostik, Identifizierung und Empfindlichkeitsprüfung von obligaten Anaerobiern. Chemotherapie Journal, 16(3), 75-87.
     
  200. Friedrichs C, Rodloff AC, Chhatwal GS, Schellenberger W, Eschrich K (2007). Rapid identification of viridans streptococci by mass spectrometric discrimination. J Clin Microbiol, 45(8), 2392-2397.
     
  201. Ott R, Hartwig T, Tannapfel A, Blatz R, Rodloff AC, Madaj-Sterba P, Mobius C, Kockerling F (2007). Biocompatibility of bacterial contaminated prosthetic meshes and porcine dermal collagen used to repair abdominal wall defects. Langenbecks Arch Surg, 392(4), 473-478.
     
  202. Kalka-Moll WM, Aurbach U, Schaumann R, Schwarz R, Seifert H (2007). Wound botulism in injection drug users. Emerg Infect Dis, 13(6), 942-943.
     
  203. Sigge A, Essig A, Wirths B, Fickweiler K, Kaestner N, Wellinghausen N, Poppert S (2007). Rapid identification of Fusobacterium nucleatum and Fusobacterium necrophorum by fluorescence in situ hybridization. Diagn Microbiol Infect Dis, 58(2), 255-259.
     
  204. Klotz M, Binder L, Beer J, Drath L, Hoffmann H und der Arbeitskreis Mykobakterien (AKM)M (2007). Auszüge aus dem Entwurf der neuen DIN 58943-4 \"Präanalytik in der Tuberkulose- und Mykobakteriendiagnostik\" Der Mikrobiologe, 17(2), 79-81.
     
  205. Rische S, Schulz M, Grimm M, Genzel G, Siekmeyer W, Kiess W (2007). Toxinbildende Staphylokokken als Verursacher einer Impetigo contagiosa und eines Staphylococcal Scalded Skin Syndroms (SSSS) Kinder- und Jugendmedizin, 7(3), 127-132.
     
  206. Handrick W, Veregge M, Spencker FB, Hügle B, Schuster V (2007). Epidemiologie invasiver Meningokokken- Infektionen bei Kindern und Jugendlichen am Beispiel einer Universitätskinderklinik - Bericht über 177 Patienten Kinder- und Jugendmedizin, 7(6), 351-354.
     
  207. Rehak M, Blatz R, Wiedemann P, Meier P (2007). [Primary vitrectomy with intraocular antibiotic application in postoperative endophthalmitis.] Ophthalmologe, 104(11), 958-964.
     
  208. Reiss-Zimmermann M, Sorge I, Schille R, Beer J, Hirsch W (2007). Yersinia enterocolitica-associated generalized microinfarctions of bone and spleen in a child. Pediatr Radiol, 37(12), 1294-1297.
     
  209. Goldstein EJC, Rodloff AC (2007). Skin and Skin Structure Infections. In: Goldstein EJC, Rodloff AC, Skin and Skin Structure Infections. (S. 1-86), London: Current Medicine Group Ltd., Part of Springer.
     


  210. 2006


  211. Fille M, Mango M, Lechner M, Schaumann R (2006). Bacteroides fragilis group: trends in resistance. Curr Microbiol, 52(2), 153-157.
     
  212. Claros MC, Claros ZC, Hecht DW, Citron DM, Goldstein EJ, Silva J Jr, Tang-Feldman Y, Rodloff AC (2006). Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Anaerobe, 12(1), 17-22.
     
  213. Rodloff AC, Schaumann R, Blatz R (2006). [Appropriate microbiological diagnostics] Internist (Berl), 47(2), 171-181.
     
  214. Wagner J, Spencker FB, Rodloff AC (2006). Aus dem Arbeitsausschuss E10 "Chemotherapeutische Untersuchungsmethoden" des Normenausschusses Medizin (NAMed) im DIN. Der Mikrobiologe, 16(1), 29-37.
     
  215. Grimm H, Halle E, Wagner J, Rodloff A (2006). In-vitro-Aktivität von Piperacillin/Tazobactam und Piperacillin/Sulbactam. Chemotherapie Journal, 15(3), 69-71.
     
  216. Aldridge KE, Pankey GA, Rodloff AC (2006). Complicated skin and skin structure infections. Part Four. Lectures in Hospital Infections, 1, 1-42.
     
  217. Handrick W, Blatz R, Spencker FB (2006). Konnatale Syphilis - eine Übersicht. Der Mikrobiologe, 16(3), 83-86.
     
  218. Rodloff AC, Goldstein EJ, Torres A (2006). Two decades of imipenem therapy. J Antimicrob Chemother, 58(5), 916-929.
     
  219. Spencker FB (2006). Stand und Perspektiven der Verbandszeitschrift „DER MIKROBIOLOGE“ Der Mikrobiologe, 16, 167-169.
     
  220. Kuhn J, Gerbershagen K, Schaumann R, Langenberg U, Rodloff AC, Mueller W, Hartmann-Klosterkoetter U, Bewermeyer H (2006). [Wound botulism in heroin addicts in Germany.] Dtsch Med Wochenschr, 131(18), 1023-1028.
     
  221. Kahlmeter G, Brown DF, Goldstein FW, Macgowan AP, Mouton JW, Odenholt I, Rodloff A, Soussy CJ, Steinbakk M, Soriano F, Stetsiouk O (2006). European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect, 12(6), 501-503.
     
  222. Kahlmeter G, Brown DFJ, Macgowan AP, Mouton JW, Rodloff A, Goldstein F, Odenholt I, Steinbakk M, Stetsiouk O, Soriano F (2006). EUCAST Technical Note on daptomycin. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee. Clin Microbiol Infect, 12(6), 599-601.
     
  223. Bauer TT, Ewig S, Rodloff AC, Müller EE (2006). Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. Clin Infect Dis, 43(6), 748-756.
     
  224. Ruffert H, Albert T, Rudolph C, Wehner M, Deutrich C, Schaumann R, Schutz L, Olthoff D (2006). [Streptococcal Toxic Shock-like Syndrome associated with detectable autoantibodies] Anasthesiol Intensivmed Notfallmed Schmerzther, 41(11), E24-E29.
     
  225. Szokodi D, Jurisch D, Schaumann R, Reinert RR, Engelmann L (2006). Streptokokken-Toxic-Shock-Syndrom (STSS) bei einer 23-jährigen Handballspielerin. [Streptococci Toxic Shock Syndrome (STSS) in a 23 years old female hand-ball player] Intensivmedizin und Notfallmedizin, 43(7), 584-588.
     
  226. Kahlmeter G, Brown DFJ, Canton R, MacGowan AP, Mouton JW, Rodloff A, Goldstein F, Odenholt I, Steinbakk M, Varaldo P, Hryniewicz W (The European Committee on Antimicrobial Susceptibility Testing (EUCA (2006). EUCAST Technical Note on linezolid. Clin Microbiol Infect, 12(12), 1243-1245.
     
  227. Rodloff AC, Schaumann R (2006). Nicht sporenbildende obligat anaerobe Bakterien. In: Mittermayer H, Allerberger F, Spektrum der Infektionskrankheiten. Diagnostik, Verlauf und zeitgemäße Therapie. Band 1. (S. 529-540), Balingen: Spitta Verlag GmbH & Co. KG.
     
  228. Rodloff AC, Schaumann R (2006). Obligat anaerobe sporenbildende Stäbchen (Clostridien). In: Mittermayer H, Allerberger F, Spektrum der Infektionskrankheiten. Diagnostik, Verlauf und zeitgemäße Therapie. Band 1. (S. 540-547), Balingen: Spitta Verlag GmbH & Co. KG.
     


  229. 2005


  230. Blatz R, Kuhn HJ, Hermann W, Rytter M, Rodloff AC (2005). [Neurosyphilis and neuroborreliosis Retrospective evaluation of 22 cases.] Nervenarzt, 76(6), 724-732.
     
  231. Schaumann R, Goldstein EJ, Forberg J, Rodloff AC (2005). Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures. J Med Microbiol, 54(8), 749-753.
     
  232. Fickweiler U, Fickweiler K (2005). The pathogen spectrum of acute bacterial rhinitis/sinusitis and antibiotic resistance HNO, 53(8), 735-740.
     
  233. Ackermann G, Thomalla S, Ackermann F, Schaumann R, Rodloff AC, Ruf BR (2005). Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea. J Med Microbiol, 54(2), 149-153.
     
  234. Schaumann R, Petzold S, Fille M, Rodloff AC (2005). Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates. Infection, 33, 368-372.
     
  235. Brauers J, Frank U, Kresken M, Rodloff AC, Seifert H (2005). Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect, 11(1), 24-30.
     
  236. Adam D, Bodmann KF, Elies W, Lebert C, Naber K, Sörgel F, Rodloff A, Vogel F, Wacha H (2005). Praxisorientierte Empfehlung zur kalkulierten Initialtherapie bakterieller Erkrankungen der Atemwege und des HNO-Bereichs bei Erwachsenen. Teil 3. Behandlung von HNO-Infektionen Arzneimitteltherapie, 23(9), 290-295.
     
  237. Oprica C, Nord CE, Kalenic S, Chmelar D, Lundgren B, Könönen E, Rautio M, Rodloff A, Bezirtzoglou E, Nagy E, Menozzi MG, Brazier J, Endtz H, Müller F, Kolman J, Hedberg M, Emtestam L, Lund B (2005). European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect, 11(3), 204-213.
     
  238. Vogel F, Naber KG, Adam D, Bodmann KF, Lebert C, Rodloff A, Sörgel F (2005). Aktuelle Bewertung der Fluorchinolone. Arzneimitteltherapie, 23(4), 130-136.
     
  239. Adam D, Bodmann KF, Elies W, Lebert C, Naber K, Sörgel F, Rodloff A, Vogel F, Wacha H (2005). Praxisorientierte Empfehlungen zur kalkulierten Initialtherapie bakterieller Erkrankungen der Atemwege und des HNO-Bereichs bei Erwachsenen. Teil 2: Behandlung von Laryngitis, Bronchitiden und Pneumonie. Arzneimitteltherapie, 23(8), 241-249.
     
  240. Lode H, Rodloff AC, Stahlmann R (2005). Angewandte Infektiologie : Pneumonie ; kleines Therapiehandbuch für Kliniker und Praktiker In: Lode H, Rodloff AC, Stahlmann R, Angewandte Infektiologie : Pneumonie ; kleines Therapiehandbuch für Kliniker und Praktiker (S. 144), Steinen: Zett-Verlag.
     
  241. Adam D, Bodmann KF, Elies W, Lebert C, Naber K, Sörgel, F, Rodloff A, Vogel F, Wacha H (2005). Praxisorientierte Empfehlungen zur kalkulierten Initialtherapie bakterieller Erkrankungen der Atemwege und des HNO-Bereichs bei Erwachsenen. In: Adam D, Vogel F, Praxisorientierte Empfehlungen zur kalkulierten Initialtherapie bakterieller Erkrankungen der Atemwege und des HNO-Bereichs bei Erwachsenen. (S. 63), Stuttgart: Wiss. Verlags-Ges..
     
  242. Kujath P, Rodloff AC (2005). Peritonitis. In: Kujath P, Rodloff AC, Peritonitis. (S. 120), Bremen: UNI-Med Verlag AG.
     


  243. 2004


  244. Schaumann R, Blatz R, Beer J, Ackermann G, Rodloff AC (2004). Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. J Antimicrob Chemother, 53(2), 318-324.
     
  245. Fickweiler U, Genest K, Fickweiler K (2004). [Inflammation of the auricle on both sides] HNO, 52(3), 248-250.
     
  246. Fickweiler K, Borte M, Fasshauer M, Spencker FB, Handrick W, Rodloff AC (2004). Meningitis due to Haemophilus influenzae type f in an 8-year-old girl with congenital humoral immunodeficiency. Infection, 32(2), 112-115.
     
  247. Ackermann G, Loffler B, Adler D, Rodloff AC (2004). In vitro activity of OPT-80 against Clostridium difficile. Antimicrob Agents Chemother, 48(6), 2280-2282.
     
  248. Ackermann G, Loffler B, Tang-Feldman YJ, Cohen SH, Silva J Jr, Rodloff AC (2004). Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector. Mol Cell Probes, 18(4), 271-274.
     
  249. Ackermann G (2004). Clostridium difficile – Aktueller Stand. Teil I: Epidemiologie, Pathogenese, Diagnostik, Therapie, Immunologie und Prophylaxe. Der Mikrobiologe, 14, 123-129.
     
  250. Blatz R, Kruppa A, Rodloff AC (2004). Aviditätsuntersuchungen spezifischer IgG im Serum von Syphilispatienten. LaboratoriumsMedizin, 28, 154-159.
     
  251. Schaumann R, Blatz R, Beer J, Rodloff AC (2004). Tierexperimentelle Untersuchungen zur Vorbereitung Klinischer Studien. Der Mikrobiologe, 14, 209-213.
     
  252. Handrick W, Nenoff P, Spencker, F-B (2004). Bemerkungen zur Stellungnahme der DSTDG zur aktuellen Situation der Syphilistherapie in Deutschland. Journal der Deutschen Dermatologischen Gesellschaft, 2, 640-641.
     
  253. Halle E, Halle H, Spencker, FB (2004). Empfehlungen zur Behandlung von Patientinnen mit gynäkologischen Infektionen. Der Mikrobiologe, 14, 173-176.
     
  254. Schaumann R, Shah PM (2004). Nosokomiale Infektionen in der Inneren Medizin, J. W. Goethe-Universität Frankfurt/Main – Eine prospektive Überwachungsstudie. Heilberufe: Kontext, 1, 1-4.
     
  255. Schaumann R, Rodloff AC (2004). Stenotrophomonas maltophilia – An important bacterial pathogen. Sociedad Iberoamericana de Información Científica (SIIC), 1, 1-8.
     
  256. Raue W, Spencker FB (2004). Prof. Dr. med. habil. Werner Handrick zum 65. Geburtstag Ärzteblatt Sachsen, 15(12), 529.
     
  257. Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M (2004). Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000). Chemotherapy, 50(3), 143-151.
     
  258. Erler W, Martin G, Sachse K, Naumann L, Kahlau D, Beer J, Bartos M, Nagy G, Cvetnic Z, Zolnir-Dovc M, Pavlik I (2004). Molecular fingerprinting of Mycobacterium bovis subsp. caprae isolates from central Europe. J Clin Microbiol, 42(5), 2234-2238.
     
  259. Pfaller MA, Diekema DJ et al. (2004). Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect, 10, 11-23.
     
  260. Koeth LM, Good CE, Appelbaum PC, Goldstein EJ, Rodloff AC, Claros M, Dubreuil LJ (2004). Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J Antimicrob Chemother, 53(6), 1039-1044.
     
  261. Vogtmann M, Beer J, Tannapfel A, Rodloff AC, Hoheisel G (2004). Zur Differenzialdiagnostik und Therapie bei Husten, Fieber, Brustschmerz und einseitigem Pleuraerguss Ärzteblatt Sachsen, 15(5), 191-193.
     
  262. Rodloff AC (2004). Haemophilus influenzae. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1003-1005), Berlin ; Heidelberg ; New York: Springer-Verlag.
     
  263. Rodloff AC (2004). Weitere Haemophilus spp. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1005-1006), Berlin ; Heidelberg ; New York: Springer-Verlag.
     
  264. Rodloff AC (2004). Gardnerella vaginalis und Mobiluncus spp. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1006-1007), Berlin ; Heidelberg ; New Yor: Springer-Verlag.
     
  265. Rodloff AC (2004). Brucella spp. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1007-1009), Berlin ; Heidelberg ; New York: Springer-Verlag.
     
  266. Rodloff AC (2004). Francisella tularensis. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1009-1010), Berlin ; Heidelberg ; New York: Springer-Verlag.
     
  267. Rodloff AC (2004). Pasteurella spp. In: Adam D, Doerr HW, Link H, Lode H, Die Infektiologie. (S. 1011), Berlin ; Heidelberg ; New York: Springer-Verlag.
     
  268. Heizmann WR, Spencker, F-B (2004). Antiinfektiöse Chemotherapie. Für Klinik und Praxis: Hinweise zur Therapie mit Antibiotika, Antimykotika, Virustatika und antiparasitären Mitteln. In: Heizmann WR, Spencker, F-B, Antiinfektiöse Chemotherapie. Für Klinik und Praxis: Hinweise zur Therapie mit Antibiotika, Antimykotika, Virustatika und antiparasitären Mitteln. (S. 1-712), Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH.
     
  269. Ackermann, G (2004). Dosierungstabellen bei Niereninsuffizienz. In: Heizmann WR, Spencker, F-B, Antiinfektiöse Chemotherapie. Für Klinik und Praxis: Hinweise zur Therapie mit Antibiotika, Antimykotika, Virustatika und antiparasitären Mitteln. (S. 649-672), Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH.